Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells. | J Biol Chem;284(16): 10561-70, 2009 Apr 17. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.

McNutt, Markey C; Kwon, Hyock Joo; Chen, Chiyuan; Chen, Justin R; Horton, Jay D; Lagace, Thomas A.

Affiliation

McNutt MC; Departments of Molecular Genetics, Biochemistry, and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

J Biol Chem ; 284(16): 10561-70, 2009 Apr 17.

Article in En | MEDLINE | ID: mdl-19224862

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, LDL / Serine Endopeptidases Limits: Humans Language: En Journal: J Biol Chem Year: 2009 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, LDL / Serine Endopeptidases Limits: Humans Language: En Journal: J Biol Chem Year: 2009 Document type: Article Affiliation country: Country of publication: